Successful treatment of mixed-type autoimmune hemolytic anemia with rituximab in a child following liver transplantation

Wolfram Haller*, Jonathan Hind, Sue Height, Ragai Mitry, Anil Dhawan

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

6 Citations (Scopus)

Abstract

Development of a severe form of mixed-type AIHA after orthotopic liver transplantation is a rare, but a life-threatening event. We report a case of mixed-type AIHA that developed in a child after hepatocyte and living-related orthotopic liver transplantation for factor VII deficiency.

Original languageEnglish
Pages (from-to)E20-E25
Number of pages6
JournalPEDIATRIC TRANSPLANTATION
Volume14
Issue number3
DOIs
Publication statusPublished - May 2010

Keywords

  • hepatocyte transplantation
  • child
  • factor VII deficiency
  • anti-CD20
  • autoimmune hemolytic anemia
  • mixed-type
  • THERAPEUTIC APHERESIS
  • DISEASES
  • SAFETY
  • EFFICACY
  • DONOR
  • CYCLOSPORINE
  • RECIPIENTS
  • DISORDERS
  • ANTIBODY
  • PATIENT

Fingerprint

Dive into the research topics of 'Successful treatment of mixed-type autoimmune hemolytic anemia with rituximab in a child following liver transplantation'. Together they form a unique fingerprint.

Cite this